Sepsis Clinical Trials Database - Free Access to 621 Studies
Access comprehensive clinical trial information for Sepsis through Pure Global AI's free database. This collection includes 621 clinical trials across multiple phases including N/A, Not Applicable, Early Phase 1. Currently, 150 trials are actively recruiting participants.
Research for Sepsis is being conducted in China, United States of America, United Kingdom and 7+ other countries. Leading sponsors include National Taiwan University Hospital and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Comparison of Nafamostat and Unfractionated Heparin in RRT for Sepsis Associated AKI
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Bayesian Basket Trial
Assessement of Microcirculation With NIRS Predicts Sepsis Development in Patients With Severe Covid-19 Pneumonia
Value of Laboratory Biomarkers in Prediction of Outcome in Septic Patients
An Acupuncture Study for People At High Risk for Sepsis
Rezafungin PK in Patients on ECMO
Thyroid and Cortisol Hormone Response to Sepsis
Clinical Trial to Evaluate MDW for Early Detection of Sepsis
Effect of Metabolic Dysfunction in Branched-chain Amino Acids on Cardiac Function in Patients With Sepsis
Precision Resuscitation With Crystalloids in Sepsis
Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients
Population Pharmacokinetic Model of Amikacin and Vancomycin in Critically Ill Patients
Evaluation of the Performance of a New Rapid Bacteremia Test in the Intensive Care Patient
Early Detection of At-risk Septic Patients
Quantification of Dilutional Anemia in the Initial Phase of Sepsis Management: Preliminary Retrospective Study
Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis
The Impact of Selective Vitamin D Receptor Activation on Clinical Outcomes in Septic Patients
Use of Presepsin in the Emergency Department
Discharge Readmission Analysis and Management in Sepsis (DReAMS-2)
A Prognostic Model Based on POCUS at ICU Admission in Critically Ill Patients With Sepsis
Pure Global AI provides free access to 621 clinical trials studying Sepsis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include National Taiwan University Hospital, Eli Lilly and Company, Emory University, among others.